Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Regenerative Medicine

Regenerative Medicine Research

Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.

Showing 531-540 of 2,298 results

Spinal Cord InjuryRegenerative Medicine

Multichannel bridges and NSC synergize to enhance axon regeneration, myelination, synaptic reconnection, and recovery after SCI

Not specified, 2023 • July 19, 2023

This study demonstrates that a combination of acute PLG bridge implantation and chronic hNSC transplantation enhances neurorepair after spinal cord injury (SCI). The PLG bridge provides a permissive e...

KEY FINDING: PLG bridge implantation modulates the cellular immune response in vivo by prolonging the macrophage/microglial response.

Read Summary
Spinal Cord InjuryRegenerative MedicineBioinformatics

Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion

Journal of Translational Medicine, 2023 • July 20, 2023

This study comprehensively maps transcriptional changes in young and old DRGs after injury, identifying hub genes and related drugs affecting axon regeneration. The research pioneers the construction ...

KEY FINDING: Identified 693 and 885 DEGs in old and young mice, respectively, after peripheral nerve injury, with shared DEGs involved in inflammatory and immune responses.

Read Summary
Spinal Cord InjuryRegenerative Medicine

A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury

Medicina, 2023 • July 1, 2023

Cell transplantation therapy using hiPSC-NS/PCs has shown promise for SCI treatment, particularly in the subacute phase. However, chronic SCI presents challenges due to scarring and other factors. The...

KEY FINDING: Cell transplantation therapy is more effective in the subacute phase of SCI than in the chronic phase.

Read Summary
Spinal Cord InjuryRegenerative MedicineNeurology

Differentiation of neurosphere after transplantation into the damaged spinal cord

JOURNAL of MEDICINE and LIFE, 2023 • April 1, 2023

The study aimed to compare the differentiation and survival of human neural stem/progenitor cells of various origins in vitro and after transplantation into the injured spinal cord of laboratory anima...

KEY FINDING: HUES6 and iPSC neurospheres displayed markers associated with glial differentiation.

Read Summary
Spinal Cord InjuryRegenerative Medicine

Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model

Stem Cells Translational Medicine, 2023 • August 24, 2023

In the current study, we presented novel findings suggesting that hiPSC-oNPCs are a promising cell source for cervical SCI treatment. We observed that these cells predominantly differentiated into oli...

KEY FINDING: Following transplantation, the oNPCs engrafted, migrated to the rostral and caudal regions of the lesion, and demonstrated preferential differentiation toward oligodendrocytes.

Read Summary
Regenerative MedicineNeurologyGenetics

Tanshinone IIA protects motor neuron-like NSC-34 cells against lipopolysaccharide-induced cell injury by the regulation of the lncRNA TCTN2/miR-125a-5p/DUSP1 axis

Regenerative Therapy, 2023 • March 31, 2023

This study demonstrates that Tanshinone IIA (TSIIA) protects motor neuron-like NSC-34 cells from lipopolysaccharide (LPS)-induced cell injury. The protective effect of TSIIA is mediated by the regulat...

KEY FINDING: TSIIA alleviates cell injury induced by LPS and increases TCTN2 expression in LPS-exposed NSC-34 cells.

Read Summary
Spinal Cord InjuryRegenerative Medicine

Exosomes derived from human placental mesenchymal stem cells in combination with hyperbaric oxygen synergically alleviates spinal cord ischemia-reperfusion injury

Regenerative Therapy, 2023 • September 4, 2023

This study investigates the combined effects of human placental mesenchymal stem cell-derived exosomes (hpMSCs-Exos) and hyperbaric oxygen (HBO) on spinal cord ischemia-reperfusion injury (IR) in rats...

KEY FINDING: The combination of hpMSCs-Exos and HBO significantly increased neuronal survival and decreased gliosis (proliferation of glial cells) in the spinal cord.

Read Summary
PharmacologyRegenerative MedicineNeurology

A spatially specified systems pharmacology therapy for axonal recovery after injury

Frontiers in Pharmacology, 2023 • September 20, 2023

The study uses a systems pharmacology approach to identify a four-drug combination (IL-6, HU-210, Taxol, and APC) that promotes axonal regeneration after injury in the rat optic nerve crush model. The...

KEY FINDING: The combination of IL-6 and HU-210 stimulates neurite outgrowth in an inhibitory environment by promoting neuroprotection and enabling neurite outgrowth.

Read Summary
Spinal Cord InjuryRegenerative MedicineNeurology

Preclinical long-term safety of intraspinal transplantation of human dorsal spinal GABA neural progenitor cells

iScience, 2023 • November 17, 2023

This study demonstrated the long-term fate and safety of human ESC-derived dorsal spinal dI4/dILA NPCs in adult naive rat spinal cords over 1 year. The majority of differentiated human neurons were PT...

KEY FINDING: Human spinal GABA neurons survived long-term and fully matured in the rat spinal cord after transplantation, differentiating into neurons and astrocytes.

Read Summary
Spinal Cord InjuryRegenerative MedicineNeurology

Advances in Management of Spinal Cord Injury Using Stem Cell-derived Extracellular Vesicles: A Review Study

Basic and Clinical Neuroscience, 2023 • July 1, 2023

This study summarizes the efficacy of MSC-EVs, including exosomes, alone or in combination with scaffolds in the treatment of SCI and then discusses the therapeutic outcomes observed in SCI experiment...

KEY FINDING: MSC-EVs, including exosomes, alone or in combination with scaffolds can can regenerate the injured nerve in SCI.

Read Summary
Previous
1...535455...230
Next